Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
13792 studies found for:    Open Studies | "Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Image-guided Cryoablation of Head, Neck and Spine Tumors
Conditions: Head and Neck Neoplasms;   Malignant Neoplasm of Vertebral Column
Interventions: Procedure: Cryoablation;   Device: Biopsy
22 Recruiting Neoadjuvant MEDI4736 Concomitant With Weekly Nab-paclitaxel and Dose-dense AC for Stage I-III Triple Negative Breast Cancer
Condition: Breast Neoplasms
Intervention: Drug: MEDI4736
23 Not yet recruiting Novel Detection System for Lung Cancer Curative Effect Monitoring
Condition: Lung Neoplasms
Intervention:
24 Recruiting Functional Image and Molecular Markers to Predict Treatment Outcomes in Lung Cancer
Condition: Lung Neoplasms
Intervention:
25 Recruiting Molecular and Genomic Profiling of Head and Neck Tumors
Condition: Head and Neck Neoplasms
Intervention:
26 Recruiting Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms
Conditions: Liver Neoplasms;   Hepatic Cancer;   Liver Cancer
Interventions: Procedure: Thermal Ablation;   Procedure: Standard External Beam Radiation Therapy
27 Recruiting Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members
Conditions: Neoplasms;   Hematologic Neoplasms
Intervention:
28 Recruiting Study of Radium-223 Dichloride Versus Placebo and Hormonal Treatment as Background Therapy in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer
Condition: Breast Neoplasms
Interventions: Drug: Radium-223 dichloride (Xofigo, BAY88-8223);   Drug: Placebo (saline);   Other: Background hormonal therapy
29 Recruiting The Role of ctDNA and PBMC in Treatment of Biliary Tract Cancer
Condition: Biliary Tract Neoplasms
Intervention: Procedure: surgery or biopsy
30 Recruiting Study of Radium-223 Dichloride Versus Placebo and Treatment With Exemestane / Everolimus in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer
Condition: Breast Neoplasms
Interventions: Drug: Radium-223 dichloride (Xofigo, BAY88-8223);   Drug: Placebo (saline);   Drug: Exemestane;   Drug: Everolimus
31 Recruiting Evaluation of Molecular Markers in Adrenal Tumors
Condition: Adrenal Gland Neoplasms
Intervention:
32 Recruiting Efficacy of Cap-assisted Chromoendoscopy as a Screening Test for Colorectal Neoplasm Using Web-based Research Network
Condition: Colorectal Neoplasm
Intervention: Device: cap-assisted chromoendoscopy
33 Recruiting Specimen Banking From Patients With Lung Cancer
Condition: Lung Neoplasms
Intervention:
34 Recruiting Surgery Plus Single Agent Chemotherapy Versus Primary Chemotherapy for Gestational Trophoblastic Neoplasms
Condition: Gestational Trophoblastic Neoplasms
Interventions: Procedure: Total abdominal hysterectomy and methotrexate;   Drug: Methotrexate plus folinic acid alone
35 Recruiting Study Evaluating the Efficacy and Safety With CAR-T for Liver Cancer
Condition: Liver Neoplasms
Intervention: Biological: EPCAM-targeted CAR-T cells
36 Recruiting Use of Fluorescein Dye for the Removal of Brain Tumors
Condition: Brain Neoplasms
Intervention: Drug: Fluorescein
37 Recruiting Lung Cancer Radiotherapy Using Realtime Dynamic Multileaf Collimator (MLC) Adaptation And Radiofrequency Tracking
Conditions: Neoplasms;   Lung Neoplasms
Intervention: Device: MLC Tracking
38 Recruiting Phase 2 Study of Standard Chemotherapy With Trastuzumab, Plus or Minus Pertuzumab, for Pre-treated Metastatic Breast Cancer
Conditions: Breast Neoplasms;   Malignant Tumor of the Breast
Interventions: Drug: Trastuzumab;   Drug: Pertuzumab;   Drug: Vinorelbine, Paclitaxel, Nab-Paclitaxel , Docetaxel, Capecitabine
39 Not yet recruiting Metabiomics Colon Cancer Clinical Research Study
Condition: Colonic Neoplasms
Intervention:
40 Recruiting Trial of Hu5F9-G4 in Combination With Cetuximab in Patients With Solid Tumors and Advanced Colorectal Cancer
Conditions: Colorectal Neoplasms;   Solid Tumors
Interventions: Drug: Hu5F9-G4;   Drug: Cetuximab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.